As part of our ongoing effort to bring you reports of interesting new studies, we have added a review of the HUYGENS study: High-resolution assessment of coronary plaques in a global evolocumab randomised study.
Independent expert commentary is provided by Associate Professor Amerena, a Cardiologist at Barwon Health and the Department of Clinical and Biomedical Sciences at the University of Melbourne and the Department of Epidemiology and Preventive Medicine at Monash University.
Please login below to download this issue (PDF)